sq-11725 has been researched along with Coronary Disease in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (78.95) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 1 (5.26) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leung, TK; Nattel, S; Rivard, L; Schram, G; Shiroshita-Takeshita, A; Sinno, H | 1 |
| Jarecki, M; Krotkiewski, A; Ruszkowski, J; Szelemetko, J; Zatorski, A | 1 |
| Borer, JS; Moses, JW | 1 |
| Frishman, WH | 1 |
| Campbell, TJ; Williams, EM | 1 |
| Dziekański, S; Goch, JH; Tkaczewski, W | 1 |
| Khvoĭnitskiĭ, VA; Ostapiuk, FE | 1 |
| Ahmad, S | 1 |
| Jimenez, AH; Muller, JE; Parker, JD; Parker, JO; Stone, PH; Testa, MA; Tofler, GH | 1 |
| Azevedo, ER; Newton, GE; Parker, JD | 1 |
| Ol'binskaia, LI; Vartanova, OA | 1 |
| Euler, DE; Scanlon, PJ; Wedel, VA | 1 |
| Metelitsa, VI | 1 |
| Aslibekian, IS; Ivanova, LN; Kirichenko, AA; Zurabian, KM | 1 |
| Blasini, R; Brügmann, U | 1 |
| Abiko, Y; Ichihara, K | 1 |
| Lucchesi, BR; Patterson, E | 1 |
| Crawford, MH; Miller, WE; O'Rourke, RA; Vittitoe, J | 1 |
| Hashimoto, H; Nakashima, M; Oguro, K; Sogabe, K; Takiguchi, Y | 1 |
2 review(s) available for sq-11725 and Coronary Disease
| Article | Year |
|---|---|
Beta-adrenergic antagonists in the treatment of patients with heart disease.
Topics: Acebutolol; Adrenergic beta-Agonists; Alprenolol; Animals; Arrhythmias, Cardiac; Bronchial Spasm; Cardiomyopathy, Hypertrophic; Coronary Disease; Female; Heart Diseases; Heart Failure; Humans; Hypertension; Metoprolol; Mitral Valve Prolapse; Mitral Valve Stenosis; Nadolol; Nervous System Diseases; Pindolol; Pregnancy; Pregnancy Complications, Cardiovascular; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Structure-Activity Relationship; Timolol | 1981 |
Nadolol: a new beta-adrenoceptor antagonist.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Coronary Disease; Hypertension; Nadolol; Propanolamines | 1981 |
7 trial(s) available for sq-11725 and Coronary Disease
| Article | Year |
|---|---|
[Clinical evaluation of nadolol in coronary disease].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Nadolol; Propanolamines | 1980 |
[Use of nadolol in coronary disease].
Topics: Adrenergic beta-Antagonists; Adult; Clinical Trials as Topic; Coronary Disease; Female; Humans; Male; Middle Aged; Nadolol; Placebos; Propanolamines; Research Design | 1983 |
[Use of the new beta-adrenoblockader Corgard in ischemic heart disease and arterial hypertension].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Clinical Trials as Topic; Coronary Disease; Humans; Hypertension; Middle Aged; Myocardial Infarction; Nadolol; Propanolamines; Propranolol; Recurrence | 1984 |
Morning increase in ambulatory ischemia in patients with stable coronary artery disease. Importance of physical activity and increased cardiac demand.
Topics: Aged; Ambulatory Care; Circadian Rhythm; Coronary Disease; Double-Blind Method; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Male; Middle Aged; Myocardial Ischemia; Nadolol; Physical Exertion; Time Factors | 1994 |
[Effectiveness of the prolonged-action beta-blockader nadolol in the treatment of ischemic heart disease].
Topics: Adrenergic beta-Antagonists; Adult; Clinical Trials as Topic; Coronary Disease; Delayed-Action Preparations; Follow-Up Studies; Humans; Middle Aged; Nadolol; Propanolamines | 1985 |
[Comparison of the effect of a selective and a nonselective beta receptor blocker on the ischemic ST segment, lung function and stress-induced decrease in blood glucose].
Topics: Adrenergic beta-Antagonists; Airway Resistance; Angina Pectoris; Betaxolol; Blood Glucose; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Electrocardiography; Exercise Test; Heart Conduction System; Heart Rate; Humans; Nadolol; Propanolamines; Random Allocation | 1986 |
Nadolol versus diltiazem and combination for preventing exercise-induced ischemia in severe angina pectoris.
Topics: Aged; Angina Pectoris; Blood Pressure; Coronary Disease; Diltiazem; Electrocardiography; Female; Heart; Heart Rate; Heart Ventricles; Humans; Male; Middle Aged; Nadolol; Physical Exertion | 1988 |
10 other study(ies) available for sq-11725 and Coronary Disease
| Article | Year |
|---|---|
The pharmacological response of ischemia-related atrial fibrillation in dogs: evidence for substrate-specific efficacy.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channel Blockers; Coronary Disease; Diltiazem; Dogs; Electric Stimulation; Flecainide; Models, Animal; Nadolol; Phenethylamines; Potassium Channel Blockers; Refractory Period, Electrophysiological; Sodium Channel Blockers; Sulfonamides; Vagus Nerve | 2007 |
The effects of nadolol on various cardiac tissues in normoxia, and on atrial muscle in simulated ischaemia.
Topics: Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Coronary Disease; Female; Heart; Heart Atria; Heart Ventricles; In Vitro Techniques; Male; Membrane Potentials; Myocardial Contraction; Nadolol; Propanolamines; Purkinje Fibers; Rabbits; Ranidae | 1982 |
Hypothyroidism-induced bradycardia.
Topics: Adrenergic beta-Antagonists; Bradycardia; Coronary Disease; Humans; Hypothyroidism; Male; Middle Aged; Nadolol | 1995 |
Inotropic and sympathetic responses to the intracoronary infusion of a beta2-receptor agonist: a human in vivo study.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Albuterol; Atenolol; Cardiac Catheterization; Chest Pain; Coronary Disease; Coronary Vessels; Female; Heart; Heart Ventricles; Hemodynamics; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Myocardial Contraction; Nadolol; Norepinephrine; Sympathetic Nervous System; Sympathomimetics | 1999 |
[Clinical and cardiohemodynamic effects of the new long-acting beta-blocker tobanum].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Cardiac Complexes, Premature; Coronary Disease; Female; Heart; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Nadolol; Propanolamines; Propranolol | 1986 |
Adrenergic influences on ischemic and reperfusion arrhythmias in a canine model with diminished collateral blood flow.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Blood Pressure; Coronary Circulation; Coronary Disease; Denervation; Dogs; Electrocardiography; Female; Heart Rate; Male; Myocardial Reperfusion Injury; Nadolol; Succinylcholine; Sympathetic Nervous System | 1989 |
[Drugs in secondary prevention of ischemic heart disease: achievements, problems and prospects].
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Coronary Disease; Female; Humans; Isosorbide Dinitrate; Male; Metoprolol; Nadolol; Nifedipine; Nitrates; Nitroglycerin; Propranolol; Verapamil | 1989 |
Effect of nadolol, a beta-adrenoceptor blocking agent, on myocardial metabolism in the dog ischaemic heart.
Topics: Adenine Nucleotides; Animals; Carbohydrate Metabolism; Coronary Disease; Dogs; Energy Metabolism; Female; Heart; Hemodynamics; Hexosephosphates; Male; Myocardium; Nadolol; Phosphocreatine | 1987 |
Electrophysiologic and antiarrhythmic actions of nadolol: acute ischemia in the presence of previous myocardial infarction.
Topics: Animals; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Coronary Disease; Coronary Vessels; Dogs; Electrocardiography; Heart Conduction System; Ligation; Male; Myocardial Infarction; Nadolol | 1988 |
Anti-arrhythmic effect of nadolol in experimental arrhythmias: comparison with propranolol and alprenolol.
Topics: Alprenolol; Anesthesia; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Disease; Dogs; Epinephrine; Female; Halothane; Male; Nadolol; Ouabain; Propanolamines; Propranolol | 1985 |